FDA Approves New Drug for Severe Crohn’s Disease Symptom Relief
FDA Approves Mirikizumab (Omvoh) for Crohn’s Disease: A New Hope for Patients The US Food and Drug Administration (FDA) has granted approval for mirikizumab (Omvoh), a groundbreaking treatment for adults with moderately to severely active Crohn’s disease. This decision, announced on January 15, 2025, marks a meaningful milestone in the fight against this chronic inflammatory … Read more